OLSALAZINE SODIUM (ol-sal'a-zeen) Dipentum Classifications: mucous membrane; antiinflammatory agent; Therapeutic: antiinflammatory; gi Prototype: Mesalamine Pregnancy Category: C |
250 mg capsules
Converted to 5-aminosalicylic acid (5-ASA) by colonic bacteria. The 5-ASA is absorbed slowly, resulting in a very high local concentration in the colon. 5-ASA inhibits prostaglandin production in the colon, thus leading to anti-inflammatory properties of the drug.
5-ASA has antiinflammatory activity in ulcerative colitis.
Maintenance therapy in patients with ulcerative colitis.
Acute flare-up of ulcerative colitis.
Hypersensitivity to salicylates or 5-ASA; pregnancy (category C).
Patients with preexisting kidney disease; lactation. Safety and effectiveness in children are not established.
Ulcerative Colitis Adult: PO 500 mg b.i.d., may increase up to 1.53 g/d in 24 divided doses |
Assessment & Drug Effects
Patient & Family Education